Methodological issues in estimating the cost of epilepsy

Epilepsy Research

Volumn 33, Issue 1, 1999, Pages 39-55

  Begley, Charles E ^a   Annegers, John F ^a   Lairson, David R ^a   Reynolds, Thomas F ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Costs; Economics; Methods; Review

Indexed keywords

ARTICLE; AUSTRALIA; EPILEPSY; HEALTH CARE COST; HUMAN; METHODOLOGY; PRIORITY JOURNAL; SWITZERLAND; UNITED KINGDOM; UNITED STATES;

AUSTRALIA; COST OF ILLNESS; COSTS AND COST ANALYSIS; EPILEPSY; GREAT BRITAIN; HUMANS; SWITZERLAND; UNITED STATES;

EID: 0033023750     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00070-9     Document Type: Article

References (29)

1. Banks, G.K., Regan, K.J., Beran, R.G., 1995. The prevalence and direct costs of epilepsy in Australia. In: Beran R.G., Pachlatko, C. (Eds.), Cost of Epilepsy: Proceedings of the 20th International Epilepsy Congress. Ciba-Geigy Verlag, Baden Germany, pp. 39-48.
2. Begley, C.E., Annegers, J.F., Lairson, D.R., Reynolds, T.F., Hauser, W.A., 1994. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 35, 1230-1243.
3. Beran, R.G., Banks, G.K., 1995. Indirect costs of epilepsy in Australia. In: Beran, R.G., Pachlatko, C. (Eds.), Cost of Epilepsy: Proceedings of the 20th International Epilepsy Congress. Ciba-Geigy Verlag, Baden, Germany, pp. 49-54.
4. Cockerell, O.C., 1996. Pharmacoeconomic considerations in the drug treatment of epilepsy. C.N.S. Drugs 6, 450-461.
5. Cockerell, O.C., Hart, Y.M., Sander, J.W.A.S., Shorvon, S.D., 1994. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res. 18, 249-260.
6. Commission for the Control of Epilepsy and its Consequences, 1978. Economic cost of epilepsy. In: Plan for Nationwide Action on Epilepsy, vol. IV, DHEW Publication no. 78-279. NIH, Washington, DC, pp. 117-148.
7. Cooper, B.S., Rice, D.P., 1976. The economic cost of illness revisited. Soc. Secur. Bull. 39, 21-36.
8. Famulari, M., 1992. The effects of a disability on labor market performance: the case of epilepsy. South. Econ. J. 58, 1072-1087.
9. Gessner, U., Sagmeister, M., Horisberger, B., 1993. The cost of epilepsy in Switzerland. Int. J. Health Sci. 4, 121-128.
10. Hartunian, N.S., Smart, C.N., Thompson, M.S., 1980. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis. Am. J. Public Health 70, 1249-1260.
11. Hauser, W.A., Annegers, J.F., Elveback, L.R., 1980. Mortality in patients with epilepsy. Epilepsia 21, 399-412.
12. Heckman, J., 1976. The common structure of statistical models of truncation, sample selection and limited dependent variables and a simple estimator for such models. Ann. Econ. Soc. Measurement, Fall, 475-492.
13. Hodgson, T.A., 1983. The state of the art of cost-of-illness estimates. Adv. Health Econ. Health Serv. Res. 4, 129-164.
14. Hodgson, T.A., 1988. Annual costs of illness versus lifetime costs of illness and implications of structural change. Drug Inf. J. 22, 323-341.
15. Hodgson, T.A., 1994. Costs of illness in cost-effectiveness analysis: a review of the methodology. Pharmacoeconomics 6, 536-553.
16. Hodgson, T.A., Meiners, M.R., 1982. Cost of illness methodology: a guide to current practices and procedures. Milbank Mem. Fund Quart. 60, 429-461.
17. Johnson, W.G., Nuwer, M.R., 1997. Cost of treating patients. In: Engel, J., Pedley, T.A. (Eds.) Epilepsy: A Comprehensive Textbook. Lippincott-Raven, Philadelphia, pp. 2893-2900.
18. King, J.T., Sperling, M.R., Justice, A.C., O'Connor, M.J., 1997. A cost-effectiveness analysis of anterior temporal lobectory for intractable temporal lobe epilepsy. J. Neurosurg. 87, 20-28.
19. Koopmanschap, M.A., Rutten, F.F.H., 1993. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 4, 446-454.
20. Luce B.R., Manning, W.G., Siegel, J.E., Lipscomb J., 1996. Estimating costs in cost-effectiveness analysis. In: Gold, M.R., Russell, L.B., Siegel J.E., Weinstein, M.C. (Eds.), Cost-Effectiveness in Health and Medicine. Oxford University Press, New York, pp. 176-213.
21. Marks, W.I., Garcia, P.A., 1998. Management of seizures and epilepsy. Am. Fam. Phys. 57, 1589-1600.
22. Murray, M.J., Halpern, M.T., Leppik, I.E., 1996. Cost of refractory epilepsy in adults in the USA. Epilepsy Res. 23, 139-148.
23. National Center for Health Statistics. Catalog of Electronic Data Products. US Department of health and Human Services, Public Health Service, CDC, Hyattsville, MD, July 1994.
24. NIH Consensus Panel, 1990. Consensus conferences on surgery for epilepsy. J. Am Med. Assoc. 264, 729-733.
25. Organization for Economic Cooperation and Development, 1987. Financing and Delivering Health Care: A Comparative Analysis of OECD Countries, Social Policy Series No. 4. OECD, Paris.
26. Robinson, J.C., 1986. Philosophical origins of the economic valuation of life. Milbank Mem. Fund Quart. 64, 133-155.
27. Scitovsky, A.A., 1982. Estimating the direct cost of illness. Milbank Mem. Fund Quart. 60, 463-491.
28. Tolpin, H.G., Bentkover, J.D., 1983. Economic cost of illness: decision-making applications and practical considerations. Adv. Health Econ. Health Serv. Res. 4, 165-198.
29. van Hout, B., Gagnon, D., Souetre, E., Ried, S., Remy, C., Baker, G., Genton, P., Vespignani, H., McNulty, P., 1997. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia 38, 1221-1226.